Sara Alberti

780 total citations
20 papers, 531 citations indexed

About

Sara Alberti is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Sara Alberti has authored 20 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Sara Alberti's work include Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Cancer, Lipids, and Metabolism (2 papers). Sara Alberti is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Cancer, Lipids, and Metabolism (2 papers). Sara Alberti collaborates with scholars based in Italy, United States and Germany. Sara Alberti's co-authors include Melania Dovizio, Paola Patrignani, Paloma Guillem‐Llobat, Dieter Steinhilber, Alessandro Sgambato, Annalisa Bruno, Angela Sacco, Thorsten J. Maier, Luigia Di Francesco and Garret A. FitzGerald and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Sara Alberti

18 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Alberti Italy	11	210	147	133	115	76	20	531
Eva Tarantino Italy	15	104 0.5×	194 1.3×	35 0.3×	70 0.6×	81 1.1×	18	596
Danilo Croci Italy	17	318 1.5×	265 1.8×	33 0.2×	102 0.9×	34 0.4×	24	902
Artur-Aron Weber Germany	8	49 0.2×	126 0.9×	88 0.7×	42 0.4×	69 0.9×	8	446
Gabriella Doronzo Italy	19	56 0.3×	294 2.0×	68 0.5×	101 0.9×	281 3.7×	37	884
L Pacchiarini Italy	14	106 0.5×	102 0.7×	42 0.3×	42 0.4×	167 2.2×	36	666
Jochen Ittner Germany	6	109 0.5×	292 2.0×	33 0.2×	66 0.6×	99 1.3×	7	577
N Kraenkel Germany	12	119 0.6×	399 2.7×	34 0.3×	120 1.0×	170 2.2×	25	799
Juergen Fingerle Switzerland	11	52 0.2×	185 1.3×	71 0.5×	96 0.8×	80 1.1×	12	611
Zhongbiao Wang United States	13	54 0.3×	202 1.4×	40 0.3×	88 0.8×	75 1.0×	27	482
Ravinder Pabla United Kingdom	11	60 0.3×	201 1.4×	24 0.2×	70 0.6×	233 3.1×	21	863

Countries citing papers authored by Sara Alberti

Since Specialization

Citations

This map shows the geographic impact of Sara Alberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Alberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Alberti more than expected).

Fields of papers citing papers by Sara Alberti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Alberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Alberti. The network helps show where Sara Alberti may publish in the future.

Co-authorship network of co-authors of Sara Alberti

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Alberti. A scholar is included among the top collaborators of Sara Alberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Alberti. Sara Alberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pantanetti, Paola, Vanessa Ronconi, Stefano Mancin, et al.. (2025). Evaluation of Clinical and Quality of Life Effects of Oral Semaglutide Use in Type 2 Diabetes from a Public Health View: A Prospective Study in Italy. Diabetology. 6(8). 80–80.

Zanconato, Giovanni, Andrea Mafficini, Serena Pedron, et al.. (2025). Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion. Acta Neuropathologica Communications. 13(1). 50–50.

Pantanetti, Paola, Giovanni Cangelosi, Sara Alberti, et al.. (2024). Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice. Frontiers in Endocrinology. 15. 1394506–1394506. 19 indexed citations

Williams, AnnaLynn M., Elizabeth Belcher, Bryan D. Thompson, et al.. (2024). Changes in S100 calcium-binding protein β (S100β) and cognitive function from pre- to post-chemotherapy among women with breast cancer. Brain Behavior & Immunity - Health. 41. 100860–100860. 1 indexed citations

Croci, Giorgio Alberto, et al.. (2023). Lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement: Successful imatinib treatment in two cases. The Journal of Dermatology. 50(10). 1330–1334. 2 indexed citations

Ferri, Paola, Sara Alberti, Pierpaolo Parogni, et al.. (2022). Pain Management in a Prehospital Emergency Setting: A Retrospective Observational Study. Journal of Pain Research. Volume 15. 3433–3445. 15 indexed citations

Contursi, Annalisa, Patrizia Ballerini, Sara Alberti, Götz Münch, & Paola Patrignani. (2022). The Novel Antiplatelet Agent Revacept in Cardiovascular Medicine: The Promise of Efficacy Without Bleeding. 3(1). 2 indexed citations

Alberti, Sara, Qianqian Zhang, Ilaria D’Agostino, et al.. (2020). The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia. Scientific Reports. 10(1). 21420–21420. 7 indexed citations

Sacco, Angela, Annalisa Bruno, Annalisa Contursi, et al.. (2019). Platelet-Specific Deletion of Cyclooxygenase-1 Ameliorates Dextran Sulfate Sodium–Induced Colitis in Mice. Journal of Pharmacology and Experimental Therapeutics. 370(3). 416–426. 28 indexed citations

10.

Barbero, Margherita, Stefano Dughera, Sara Alberti, & Giovanni Ghigo. (2018). A simple, direct synthesis of 3-vinylindoles from the carbocation-catalysed dehydrative cross-coupling of ketones and indoles. A combined experimental and computational study. Tetrahedron. 75(3). 363–373. 4 indexed citations

11.

Marcos, Ricardo de la Vega, Sara Alberti, Roberto Ruiz Barquín, István Soós, & Attila Szabó. (2017). Induced beliefs about a fictive energy drink influences 200‐m sprint performance^†. European Journal of Sport Science. 17(8). 1084–1089. 12 indexed citations

12.

Guillem‐Llobat, Paloma, Melania Dovizio, Annalisa Bruno, et al.. (2016). Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget. 7(22). 32462–32477. 132 indexed citations

13.

Dovizio, Melania, Sara Alberti, Angela Sacco, et al.. (2015). Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk. Biochemical Society Transactions. 43(4). 707–714. 31 indexed citations

14.

Francesco, Luigia Di, Melania Dovizio, Annalisa Trenti, et al.. (2015). Dysregulated post‐transcriptional control ofCOX‐2 gene expression in gestational diabetic endothelial cells. British Journal of Pharmacology. 172(18). 4575–4587. 9 indexed citations

15.

Guillem‐Llobat, Paloma, Melania Dovizio, Sara Alberti, Annalisa Bruno, & Paola Patrignani. (2014). Platelets, Cyclooxygenases, and Colon Cancer. Seminars in Oncology. 41(3). 385–396. 34 indexed citations

16.

Dovizio, Melania, Thorsten J. Maier, Sara Alberti, et al.. (2013). Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells. Molecular Pharmacology. 84(1). 25–40. 99 indexed citations

17.

Dovizio, Melania, Sara Alberti, Paloma Guillem‐Llobat, & Paola Patrignani. (2013). Role of Platelets in Inflammation and Cancer: Novel Therapeutic Strategies. Basic & Clinical Pharmacology & Toxicology. 114(1). 118–127. 72 indexed citations

18.

Younes, Anas, Ian W. Flinn, Jesús G. Berdeja, et al.. (2013). Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL).. Journal of Clinical Oncology. 31(15_suppl). 8502–8502. 11 indexed citations

19.

Foroni, Chiara, Rossella Galli, Barbara Cipelletti, et al.. (2007). Resilience to Transformation and Inherent Genetic and Functional Stability of Adult Neural Stem Cells Ex vivo. Cancer Research. 67(8). 3725–3733. 51 indexed citations

20.

Alberti, Sara. (2003). Preface:Workshop Emerging Molecular Markers in Oncology: Focused Therapy, Indicators of Response, Chemoprevention. The International Journal of Biological Markers. 18(1). 35–35. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact